Evidence map›Paper›PMID 36114752›Full record

ArticleThoracic cancer2022

Evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer.

Makoto Tomoyasu, Hiroyuki Deguchi, Satoshi Kudo, Wataru Shigeeda, Yuka Kaneko, Ryuichi Yoshimura, Hironaga Kanno, Hajime Saito

Open access · goldAbstract read
In one paragraph

Article in Thoracic cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Makoto TomoyasuDepartment of Thoracic Surgery, School of Medicine, Iwate Medical University, Yahaba, Shiwa, Iwate, Japan.ORCID 0000-0002-7549-6763
Hiroyuki DeguchiDepartment of Thoracic Surgery, School of Medicine, Iwate Medical University, Yahaba, Shiwa, Iwate, Japan.
Satoshi KudoDepartment of Thoracic Surgery, School of Medicine, Iwate Medical University, Yahaba, Shiwa, Iwate, Japan.
Wataru ShigeedaDepartment of Thoracic Surgery, School of Medicine, Iwate Medical University, Yahaba, Shiwa, Iwate, Japan.
Yuka KanekoDepartment of Thoracic Surgery, School of Medicine, Iwate Medical University, Yahaba, Shiwa, Iwate, Japan.
Ryuichi YoshimuraDepartment of Thoracic Surgery, School of Medicine, Iwate Medical University, Yahaba, Shiwa, Iwate, Japan.
Hironaga KannoDepartment of Thoracic Surgery, School of Medicine, Iwate Medical University, Yahaba, Shiwa, Iwate, Japan.
Hajime SaitoDepartment of Thoracic Surgery, School of Medicine, Iwate Medical University, Yahaba, Shiwa, Iwate, Japan.ORCID 0000-0003-0912-1637
Iwate Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBleeding from the pulmonary artery (PA) can be fatal in video-assisted thoracoscopic surgery (VATS) for lung cancer. We evaluated intraoperative PA injury and assessed precautions for thoracoscopic anatomic pulmonary resection.

methodsWe retrospectively analyzed a total of 1098 patients who underwent radical surgery for lung cancer utilizing complete VATS from January 2010 to December 2021.

resultsA total of 16 patients (1.5%) had PA injury during VATS, while hemostasis was performed by conversion to thoracotomy in eight patients (50.0%). Although there was a significantly greater operation time and blood loss for patients in the PA injury group (318.4 vs. 264.9 min, p = 0.001; 550.3 vs. 60.5 g, p ≤ 0.001, respectively), there was no significant different for the chest tube insertion duration and length of postoperative hospital stay (4.9 vs. 7.8 days, p = 0.157; 10.6 vs. 9.9 days, p = 0.136, respectively). There was a significant difference observed for the surgical procedure related to the left upper lobectomy in the PA injury group (43.8 vs. 18.8%, p = 0.012), with the primary causative PA determined to be the left anterior segmental PA (A

conclusionsVATS is both feasible and safe for lung cancer treatment provided the surgeon performs appropriate hemostasis, although fatal vascular injury could potentially occur during VATS. Surgeons need to be aware of the pitfalls regarding PA dissection management.

Indexed as

Blood Loss, SurgicalLung NeoplasmsPulmonary ArteryThoracic Surgery, Video-AssistedHumansRetrospective Studiesleft anterior segmental pulmonary artery (A3)pulmonary artery injuryvascular staplervideo-assisted thoracoscopic surgery

Identifiers

PMID36114752
PMCPMC9626345
OpenAlexW4296120362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.